Indeed AXL dimerization and phosphorylation of EGFR leads to the activation of phospholipase C gamma and protein kinase C that results in the activation of mTOR signaling to promote resistance to PI3K inhibition in head and neck cancer [75]. This evidence concerns the gene EGFR and head and neck cancer.